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Background: Multi-centre intervention studies tackling urinary catheterization and its
infectious and non-infectious complications are lacking.
Aim: To decrease urinary catheterization and, consequently, catheter-associated urinary
tract infections (CAUTIs) and non-infectious complications.
Methods: Before/after non-randomized multi-centre intervention study in seven hospitals
in Switzerland. Intervention bundle consisting of: (1) a concise list of indications for uri-
nary catheterization; (2) daily evaluation of the need for ongoing catheterization; and (3)
education on proper insertion and maintenance of urinary catheters. The primary outcome
was urinary catheter utilization. Secondary outcomes were CAUTIs, non-infectious com-
plications and process indicators (proportion of indicated catheters and frequency of
catheter evaluation).
Findings: In total, 25,880 patients were included in this study [13,171 at baseline (August
eOctober 2016) and 12,709 post intervention (AugusteOctober 2017)]. Catheter uti-
lization decreased from 23.7% to 21.0% (P¼0.001), and catheter-days per 100 patient-days
decreased from 17.4 to 13.5 (P¼0.167). CAUTIs remained stable at a low level with 0.02
infections per 100 patient-days (baseline) and 0.02 infections (post intervention)t of Infectious Diseases,
3010 Bern, Switzerland.
(J. Marschall).
y Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article
mons.org/licenses/by/4.0/).
A. Schweiger et al. / Journal of Hospital Infection 106 (2020) 364e371 365(P¼0.98). Measuring infections per 1000 catheter-days, the rate was 1.02 (baseline) and
1.33 (post intervention) (P¼0.60). Non-infectious complications decreased significantly,
from 0.79 to 0.56 events per 100 patient-days (P<0.001), and from 39.4 to 35.4 events per
1000 catheter-days (P¼0.23). Indicated catheters increased from 74.5% to 90.0%
(P<0.001). Re-evaluations increased from 168 to 624 per 1000 catheter-days (P<0.001).
Conclusion: A straightforward bundle of three evidence-based measures reduced catheter
utilization and non-infectious complications, whereas the proportion of indicated urinary
catheters and daily evaluations increased. The CAUTI rate remained unchanged, albeit at
a very low level.
ª 2020 The Author(s). Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
The use of transurethral urinary catheters is common in
acute care hospitals. With catheterization proportions of
12e25% [1e5] and nearly 1.5 million hospitalizations in Swit-
zerland in 2016 (Source: Federal Statistics Office, accessed 27th
February 2018), it is estimated that more than 200,000 urinary
catheters are placed in Switzerland each year, eventually
causing infectious and non-infectious complications, increased
morbidity and mortality, and additional healthcare costs.
Catheter-associated urinary tract infections (CAUTIs) are a
well-known complication of urinary tract catheterization, with
rates ranging from 0.2 to 4.8 per 1000 catheter-days. Non-
infectious complications from catheterization have not
received widespread attention to date [6,7], although they
may be as common as CAUTIs [8,9]; they include mechanical
trauma to the lower urinary tract, false passage, and acci-
dental inflation of a catheter balloon in the urethra or prostate.
Up to 5% of all catheterized patients develop acute gross
haematuria, and approximately 3% suffer urethral strictures in
the long term [8].
The presence of a urinary catheter and the duration of
catheterization are the main risk factors for catheter-
associated complications; however, 21e65% of all catheter
insertions are not necessary [10e12], and prolonged cathe-
terization without clear indication is common [5,13].
Therefore, prior intervention studies have focused on the
following main pillars: (1) strict indications for catheter
insertion; (2) rapid removal of unnecessary urinary catheters;
and (3) proper insertion of and care for urinary catheters. For
example, the Keystone Bladder Bundle Initiative implemented
a protocol for catheter utilization, reminders and stop orders,
use of alternative strategies for urinary management, portable
ultrasound to measure bladder volume, and adherence to
protocols for insertion of and care for urinary catheters. Con-
sequently, the CAUTI rate decreased by 25% and 6% in the state
of Michigan and the entire USA, respectively [14,15]. Based on
this success, several programmes started worldwide and pro-
duced similar results [16e19]. In Switzerland, a few single-
centre studies have addressed urinary catheterization
[20e22]; however, a uniform nationwide approach has been
lacking to date. As such, the aim of this study was to reduce
urinary catheterization by implementing a three-fold bundle:
(1) a nationally endorsed list of indications for urinary cathe-
terization; (2) daily evaluation of the need for ongoing cathe-
terization; and (3) education on proper insertion and
maintenance of a urinary catheter.Methods
A before/after non-randomized multi-centre intervention
study, corresponding to a quasi-experimental study type 1, was
conducted [23]. The primary outcome was urinary catheter
utilization. Secondary outcomes were symptomatic CAUTIs,
non-infectious outcomes and process indicators, such as the
proportion of indicated catheters and the frequency of cath-
eter evaluation. It was hypothesized that the intervention
would significantly reduce catheter utilization, and infectious
and non-infectious complications, and significantly improve
process indicator endpoints. The study design and results
presented here were an integral part of the ‘Progress! Safe
urinary catheterization’ pilot programme that ran from 2015 to
2018 in Switzerland. In addition to the awareness campaign
that accompanied the programme and started in 2016 after
completion of the baseline surveillance, two large surveys
were launched in parallel to the baseline and intervention
periods, respectively; their goal was to better understand
knowledge, perceptions, attitudes and behaviours of health-
care workers (HCWs) surrounding the topic of urinary cathe-
terization [24,25].Sample size calculation
A baseline prevalence of urinary catheterization of 15% and
a potential relative reduction of 10% following the intervention
were assumed. Given a two-sided statistical significance of 5%
and statistical power of 80%, at least 8524 patients were
required in each group (17,048 overall) to detect a significant
difference.Surveillance
Surveillance was performed for catheterization, and infec-
tious and non-infectious complications prior to (AugusteOc-
tober 2016; baseline surveillance) and after (AugusteOctober
2017; postintervention surveillance) implementation of the
intervention. All patients hospitalized in participating hospi-
tals, irrespective of the location of catheter placement (i.e.
emergency room, operating room or other), during the baseline
and postintervention periods were included in the analysis.
Refusal of general consent to use of data for scientific research
led to patient exclusion. Data were entered into an online
database provided by the Clinical Trials Unit of the University
of Bern, Switzerland using Secutrial (Interactive Systems
GmbH, Berlin, Germany). Data consisted of demographic data,
Table I
List of indications for urinary catheter insertion per the Swiss ‘Progress! Safe urinary catheterization’ programme
Indication Specification Examples
Urinary retention  Acute urinary retention regardless of aetiology
 Symptomatic chronic outlet obstruction plus >300 mL
residual urine
 Benign hyperplasia of prostate gland, urethral
strictures, bladderstones





 At regular intervals (hourly or as defined by hospitals) plus
direct consequence on treatment of patients
 Fluid balance if patient weight not measurable on a daily
basis
 Haemodynamic instability, severe
rhabdomyolysis
 Coma, sedated and ventilated patient
Surgery  Long surgery (>4 h)
 Peri-interventional: need for empty bladder during
surgery, removal of catheter after surgery necessary if
no other indication present





 Stage III or IV pressure ulcers or skin transplants in sacral/
perineal region plus urinary incontinence after exhaustion
of alternative strategies for urinary management
Prolonged
immobilization
 Immobilization for medical reasons, especially for pain
management, after exhaustion of alternative strategies
for urinary management
 Acute fractures with severe pain due to patient
movement (pelvic fractures, fracture of the
neck of the femur)
 Haemodynamic instability possibly caused by
movement of the patient




 Palliative care plus abnormal bladder function plus/or
inability for regular voiding after exhaustion of
alternative strategies for urinary management
 High burden of suffering plus wish of informed patient (or
relatives)
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date), catheter-specific data (time and duration of catheter-
ization, type of catheter, re-insertion of further catheters),
process parameters (indication for catheterization, frequency
of evaluation) and complications (CAUTI, urethral bleeding,
gross haematuria, paraphimosis, incorrect positioning, re-
insertion within 24 h, unintentional removal, catheter
obstruction). Process parameters were only considered to be
executed if documented in the patient’s chart. The study group
trained local surveillance teams in workshops and at site visits
prior to the surveillance. In addition, audits were performed on
site in the postintervention surveillance to ensure the quality
of data.
Intervention
Seven pilot hospitals in Switzerland were included in the
intervention, including university hospitals, and tertiary, sec-
ondary and primary care centres. The three major language
regions (German, French and Italian) were represented. Each
hospital formed a project group with a dedicated leader.
Education in the form of a project handbook, workshops on the
use of urinary catheters, content of the intervention, surveil-
lance methodology and site visits was provided prior to and
during the project. To accommodate local differences, strict
instructions were not provided; rather, hospitals were free to
design how to deliver the intervention as long as they followedthe primary components of the intervention bundle. Except for
one larger hospital that participated as a whole, each hospital
was required to capture 100e200 of their surgical beds for
surveillance purposes (i.e. either the whole hospital in the case
of a smaller institution or selected wards in a larger hospital).
The bundle was implemented on participating wards as well as
units with a central function for the hospital (e.g. emergency
room, operating room and similar). The intervention bundle
consisted of an evidence-based indication list, the instruction
to evaluate this indication daily, and training HCWs in the
correct, non-traumatic and aseptic insertion of urinary cathe-
ters. The indication list (Table I) consisted of six major indi-
cations: (1) urinary retention; (2) monitoring of fluid input and
output; (3) surgery; (4) pressure ulcers and urinary incon-
tinence; (5) prolonged immobilization; and (6) palliative care
and comfort for patients. A group of national experts including
physicians and nurses developed the indications specifically for
this programme based on the Ann Arbor Criteria for Appro-
priate Urinary Catheter Use in Hospitalized Medical Patients
[26]. The list included practical examples, specific situations in
which urinary catheterization is unnecessary, and alternative
methods for urinary management. Daily evaluation of the
catheter indication was an explicit goal, and unnecessary
catheters were expected to be removed on the same day.
Finally, theoretical and practical training of HCWs ensured that
catheter insertion was only performed by adequately trained
personnel. The education had to include a ‘refresher course’
Table II
Definition of symptomatic catheter-associated urinary tract infection [27]
Criteriona
1. Epidemiological Patient had an indwelling urinary catheter that had been in place for >2 days on the date of the event and was
either:
 present for any portion of the calendar day on the date of the event or
 removed the day before the date of the event
2. Clinical Patient has at least one of the following signs or symptoms:
 fever (>38.0C)
 suprapubic tenderness
 costovertebral angle pain or tenderness
 urinary urgency (only if catheter removed)
 urinary frequency (only if catheter removed)
 dysuria (only if catheter removed)
3. Microbiological Patient has a urine culture with no more than two species of organisms identified, at least one of which is
present at 105 colony-forming units/mL
a All three criteria must be met, and have to occur during the window of infection.
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consisted of general information on urinary catheters and
alternatives for urine diversion, CAUTIs, non-infectious com-
plications, and insertion of and care for catheters. Also, a 10-
min educational video was produced by one institution and
displayed the indication list, the proper insertion technique
and elements of catheter maintenance; this was made avail-
able to all pilot hospitals in the local language. In addition,
certain hospitals offered practical training on dummies. This
intervention bundle was implemented from February 2017,
after a workshop had convened all local project leaders and
representatives for both infection prevention and quality
management from the participating hospitals, and was moni-
tored until October 2017, when the postintervention surveil-
lance ended.Definitions
CAUTI was defined in accordance with the 2015 Centers
for Disease Control and Prevention National Healthcare
Safety Network criteria, as described in Table II [27]. Only
events of ‘symptomatic CAUTI’ were included in the analysis.
Non-infectious complications due to urinary catheterization
are defined less succinctly in the literature; in this study,
urethral bleeding was defined as frank hemorrhage from the
urogenital tract, gross haematuria was defined as blood-
tinged urine, paraphimosis was defined as constriction of
the prepuce, catheter obstruction was defined as absence of
urine flow, incorrect positioning (false passage, malplace-
ment) was defined as the need to reposition a recently
placed catheter, and unintentional catheter removal was
defined as removal not ordered by the medical team. The
need for catheter re-insertion within 24 h was also consid-
ered a complication. For analyses, these complications were
grouped into medical (the first four) and procedural (the last
three) complications.
The following terms were used to calculate complication
rates:
Catheter-days ¼ [day of removal] e [day of insertion] þ 1
Patient-days ¼ [day of discharge] e [day of admission] þ 1Statistical analysis
Patients from one centre were excluded from the analyses
of non-infectious complications and indicated catheters, as
these items had not been recorded during baseline surveil-
lance. Patients from three centres were excluded from evalu-
ation of the daily re-evaluation rate as this information was not
collected during baseline surveillance. For binary endpoints,
the proportion with a 95% Wilson confidence interval (CI) in
each phase is shown. For count endpoints, rates (per 100 or per
1000 days) with a 95% exact CI are presented.
Mixed-effects, generalized, linear models were used for
comparison of the before/after surveillance periods. A bino-
mial distribution with logit-link was used for binary endpoints.
A negative binomial distribution with log-link fitted with a
square increase of variance was used for count endpoints. A
random intercept for hospitals was integrated in the models to
account for interhospital heterogeneity. In models for count
endpoints, the number of patient- or catheter-days was con-
sidered as exposure. They were also corrected for zero infla-
tion. Due to the small number of CAUTIs, it was not possible to
apply a model with negative binomial distribution. Instead, a
Poisson distribution with a random intercept for hospitals and
patients was used to control for overdispersion.
Differences between the two periods are depicted as
adjusted odds ratios (aOR) or rate ratios (aRR) for binary and
count endpoints, respectively, with a 95% CI. The ratios were
adjusted for age, sex, organizational unit and provenance of
the patient. All provenances except for ‘hospital admission
from home’ were merged due to low patient numbers. With
regard to organizational units, internal medicine, gynaecology
and intensive care units (ICUs) were also merged for adjust-
ment due to low patient numbers in gynaecology and intensive
care.
All analyses were performed using the statistical package R
(R-project 3.2).
Results
Data on 25,880 patients were analysed, with 13,171 patients
included at baseline (AugusteOctober 2016) and 12,709
patients included post intervention (AugusteOctober 2017)
Table III
Overview of outcome data before (baseline) and after an intervention aimed at reducing unnecessary urinary catheterization
Baseline surveillance Postintervention surveillance






valueOdds or rate ratio
(95% CI)





23.69 (22.97e24.42) 21.02 (20.32e21.73) 0.83 (0.79e0.89) 0.90 (0.84e0.96) 0.001
Catheter-days/100 patient-days
overall




0.02 (0.01e0.03) 0.02 (0.01e0.03) 1.00 (0.51e1.99) 1.01 (0.51e2.00) 0.983




0.79 (0.72e0.86) 0.56 (0.51e0.63) 0.75 (0.63e0.90) 0.73 (0.61e0.88) <0.001
Complications/1000 catheter-
days




74.49 (72.80e76.11) 90.03 (88.72e91.20) 3.70 (3.06e4.47) 4.08 (3.35e4.95) <0.001
Re-evaluations/1000 catheter-
days
167.66 (159.50e176.13) 623.92 (604.99e643.29) 3.08 (2.87e3.31) 3.13 (2.92e3.36) <0.001
CAUTI, catheter-associated urinary tract infection; CI, confidence interval.
a Adjusted for age, sex, organizational unit and provenance of patients.
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20.13] years and 53% were female. The minimum number of
patients accrued from a single hospital during the study period
was 1903 and the maximum was 8584. Most patients were
either from general medical or surgical wards, with the relative
contributions varying between the participating hospitals. In
total, 3494 catheters were placed during the baseline period
and 2929 were placed during the postintervention period. The
mean duration of catheterization decreased from 4.8 (SD 5.82)
days to 4.1 (SD 4.16) days between the two periods. Informa-
tion on the catheter material for all catheters (2956 at baseline
and 2375 post intervention) was not received; however, themix
of known materials was 84% silicone, 10% latex and 6% others
(coated and irrigation catheters) (baseline), and 70% silicone,
24% latex and 6% others (post intervention).
The proportion of catheterized inpatients decreased from
23.7% to 21.0% (aOR 0.90, 95% CI 0.84e0.96; P¼0.001), and in
terms of catheter-days per 100 patient-days decreased from
17.4 to 13.5 (aRR 0.96, 95% CI 0.90e1.02; P¼0.167). The
CAUTI rate remained stable at a low level with 0.02 infections
per 100 patient-days (baseline) and 0.02 infections per 100
patient-days (post intervention) (aRR 1.01, 95% CI 0.51e2.00;
P¼0.98). In an alternative approach, measuring infections per
1000 catheter-days, the rate was 1.02 (baseline) and 1.33
(post intervention) [aRR 1.20, 95% CI 0.60e2.39; P¼0.6). Non-
infectious complications decreased significantly, from 0.79 to
0.56 events per 100 patient-days (aRR 0.73, 95% CI 0.61e0.88;
P<0.001), and from 39.4 to 35.4 events per 1000 catheter-
days (aRR 0.90, 95% CI 0.77e1.07; P¼0.23). The mostcommon non-infectious complications were gross haematuria
(235 cases out of 17,296 patient episodes; 1.4%), uninten-
tional catheter removal (72/17,296; 0.4%) and urethral
bleeding (56/17,296; 0.3%). When grouping non-infectious
complications into ‘medical complications’ and ‘procedural
complications’, medical complications decreased from 188/
8887 (2.1%) to 80/8409 (0.95%) (aOR 0.46, 95% CI 0.35e0.60;
P<0.001), without a significant decrease in procedural com-
plications [i.e. 222/8887 (2.5%) vs 183/8409 (2.2%); aOR 0.87,
95% CI 0.71e1.06; P¼0.161). Except for paraphimosis, all
types of medical complications decreased significantly [ure-
thral bleeding: 38/8887 (0.4%) vs 18/8409 (0.2%); aOR 0.54,
95% CI 0.31e0.95; P¼0.031; macrohaematuria: 164/8887
(1.9%) vs 71/8409 (0.8%); aOR 0.47, 95% CI 0.36e0.63;
P<0.001; removal of an obstructed catheter: 21/8887 (0.2%)
vs 7/8409 (0.1%); aOR 0.36, 95% CI 0.15e0.83; P¼0.016].
Indicated catheters increased from 74.5% to 90.0% (aOR 4.08,
95% CI 3.35e4.95; P<0.001). Documented re-evaluations
increased from 168 to 624 per 1000 catheter-days (aRR 3.13,
95% CI 2.92e3.36; P<0.001).
The most common reasons for placing the first urinary
catheter were surgery (61% at baseline and 57% post inter-
vention), urine monitoring (16% at baseline and post inter-
vention) and urinary retention (13% at baseline and 17% post
intervention). Re-insertions were mainly due to urinary
retention (60% vs 66%), surgery (21% vs 18%) and urine mon-
itoring (14% vs 10%).
Age, sex, organizational unit and origin of the patient had an
impact on catheter utilization, rate of non-infectious
A. Schweiger et al. / Journal of Hospital Infection 106 (2020) 364e371 369complications and compliance with process parameters. Data
are provided in Table S1 (see online supplementary material).Discussion
This multi-centre intervention study is the first to shed light
on urinary catheter utilization, its infectious and non-
infectious consequences, and the impact of an evidence-
based bundle of prevention measures on these outcome
measures. In the seven pilot hospitals, almost every fourth
inpatient was catheterized, and these patients experienced
many more non-infectious complications than CAUTIs at base-
line. A straightforward three-fold intervention e consisting of
distributing an indication list for placing a catheter, promoting
daily evaluation for ongoing need of a urinary catheter, and
ensuring adequate education in catheter handling e managed
to decrease catheter utilization and non-infectious complica-
tions, and increase the proportion of documented justified
catheterization and the frequency of documented daily cath-
eter evaluations. The authors were unable to determine if this
increase was due to raised awareness because of the study or
general improvements in documentation, or if it is misleading
in the sense that practices before the intervention were cor-
rect but simply not documented properly. In summary, this
pilot study has set the stage for planning a national surveillance
and disseminating the successfully piloted intervention tools.
While certain countries have set up CAUTI surveillances, this
has not been the case for Switzerland, where urinary catheters
are the first medical device to come under scrutiny. Elsewhere,
regional [16] and national [28] studies have demonstrated that
device use can be reduced (along with the corresponding
complications from unnecessary and incorrect device place-
ment). Among the best evidence currently available is a study
by Saint et al., who selected the three core elements ‘daily
assessment of the need for a catheter’, ‘avoiding catheter use
by considering alternatives’ and ‘emphasizing the importance
of aseptic insertion technique’ to form their intervention in 926
ICU and non-ICU settings in North America, and succeeded in
lowering CAUTI rates [28]. The majority of intervention studies
published to date, however, are single-centre preepost studies
that used different combinations of measures in their inter-
vention bundles [29e34]. It therefore remains to be deter-
mined which combination of measures provides the best
balance between required effort and expected effect.
The present study attempted to replicate the success of
the studies cited above. For this purpose, a relatively
straightforward bundle was assembled, of which two elements
appear to be the most relevant drivers to reduce unnecessary
catheter use: (1) offering an evidence-based indication list for
catheter placement; and (2) prompting HCWs to evaluate the
need for ongoing catheterization [19]. A concise list of indi-
cations for catheterization, along with a description of sit-
uations that do not warrant catheterization, is the primary
step towards the reduction of unnecessary catheterization
[14], and several evidence-based indication lists are available
in the literature [4,26,35,36]. The use of reminders or stop
orders facilitates the daily re-evaluation of a catheter’s indi-
cation and potential for removal, thus reducing complications
[14,19,37,38]. The third element, ensuring that HCWs are
trained properly in the aseptic insertion of urinary catheters
and subsequent maintenance, lacks the level of supportingevidence of the other bundle components, yet is a prominent
feature in recent CAUTI prevention guidelines [39] and was
therefore included in the bundle [35,40]. The authors inten-
tionally left the participating hospitals to decide how they
planned to deliver the intervention bundle. This permitted
electronic capturing of the catheterization indication in one
of the pilot hospitals, whereas other hospitals relied on simply
disseminating the indication list among their workforce.
Despite the flexibility of this approach, the authors are fully
aware of the corresponding heterogeneity, which was evi-
denced during site visits by the study team. The issue of
implementation challenges, however, is not new to CAUTI
prevention efforts and should even be expected [19]. It is felt
that the intervention bundle assembled for this study is
intuitive and easy to memorize and convey. Given that the
optimal bundle is yet to be determined, it seems sensible to
keep the number of bundle components small.
In contrast to previous studies, this collaboration of infec-
tion prevention and patient safety experts also meant that e in
addition to the primary endpoint (urinary catheter utilization)
e both infectious and non-infectious complications were tar-
geted. Although the importance of non-infectious complica-
tions of urinary catheters was highlighted in a recent multi-
centre study [7], to the best of the authors’ knowledge, no
trials have been launched with these complications in mind. It
is worth noting that this study found that non-infectious com-
plications (both medical and procedural) were more common
than CAUTI events e this may change how preventable harm is
viewed in future surveillance surrounding urinary catheters.
Considering these results, policy makers may opt to forego
CAUTI surveillance in favour of surveillance of non-infectious
complications.
As a sizable proportion of inpatients were expected to have
an indwelling urinary catheter in the baseline surveillance,
catheter utilization was chosen as the primary endpoint, and
the sample size calculation was based on this variable. The
results indicate that catheter utilization decreased, but an
effect on CAUTIs could not be corroborated. Consequently,
focusing on the reduction of catheter utilization may be a
more cost-effective approach to surveillance than focusing on
complications of catheterization, particularly in settings
where the CAUTI rate is very low. Similarly, Fakih et al. pro-
posed the ‘device utilization ratio’ as a measure when
undertaking device stewardship or quality improvements
efforts [41].
While this study selected a three-component intervention
bundle and promoted it as such, the programme also included a
broad awareness campaign, during which media releases were
issued. Moreover, the HCWs of the participating pilot hospitals
received a detailed questionnaire on their knowledge about
urinary catheterization, their attitudes and their practices,
both at baseline [24] and post intervention [25]. The results
suggest that changes occurred over the course of the study. As
such, the questionnaire can be viewed as an additional com-
ponent which helped raise awareness and self-reflection con-
cerning local practices.
This was not a randomized study, and it is possible that
certain differences between the baseline and postintervention
populations were not accounted for. The uptake of the inter-
vention was only partially monitored (i.e. with respect to the
daily re-evaluation); it is known that subtle differences in the
implementation of infection prevention interventions are a
A. Schweiger et al. / Journal of Hospital Infection 106 (2020) 364e371370major confounder when assessing the effects of administered
measures. The participating hospitals e being ‘volunteers’ and
possibly top performers e may have exhibited lower levels of
urinary catheterization and its infectious and non-infectious
complications than other Swiss hospitals, and therefore may
not be representative for the country. Also, thorough infor-
mation on past CAUTI prevention activities in the study hospi-
tals was not collected. Finally, the mix of catheter materials
may have influenced the complication rates. Unfortunately, it
was not possible to determine the catheter material employed
in all cases, and therefore it is not possible to draw a robust
conclusion.
In conclusion, in this before/after intervention study of
urinary catheter utilization, a straightforward bundle of three
evidence-based measures (provision of a catheter indication
list, promotion of daily catheter evaluation and teaching state-
of-the-art catheter insertion) reduced catheter utilization and
led to increases in indicated urinary catheters and daily eval-
uations. The intervention had an impact on non-infectious
complications, whereas the CAUTI rate remained at a low
level, The next step is planning the national roll-out of both the
surveillance module and the intervention bundle, the compo-
nents of which have been made available to the public.Acknowledgements
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